www.dailypolitical.com ·
Yanni Associates Investment Advisors Llc Invests 588000 in Bristol Myers Squibb Company Bmy
Topic context
This topic has been covered 365745 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe article reports routine institutional investment activity in Bristol Myers Squibb, a pharmaceutical company. No new product, pipeline, regulatory, or supply chain developments are mentioned. The commercial mechanism is weak; the investment does not signal a change in BMY's revenue, margin, or competitive position. Sector impact is limited to general pharma/biotech exposure.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Yanni & Associates invested $588,000 in Bristol Myers Squibb (BMY) by purchasing 10,900 shares in Q4.
- Bristol Myers Squibb reported quarterly revenue of $11.49 billion and EPS of $1.58, beating estimates.
- BMY declared a quarterly dividend of $0.63 per share, yield 4.4%.
- 76.41% of BMY stock is owned by institutional investors.
Related stories
finance.yahoo.com
Ncmi Q1 2026 Earnings Transcript
finance.yahoo.com
Transcript Valneva Q1 2026 Earnings
fool.com
Keysight Keys Q2 2026 Earnings Transcript
fool.com
Canaan Can Q1 2026 Earnings Transcript
livemint.com